The iconic rise of Viagra has firmly established as a symbol of pharmaceutical success, but its future within the broader market now presents questions about long-term yields . Copycat versions are undercutting patent protection , leading to anxieties that betting on companies heavily reliant to Viagra's former position could be a problematic strat